129 related articles for article (PubMed ID: 17681974)
21. Prediction of genomewide conserved epitope profiles of HIV-1: classifier choice and peptide representation.
Xiao Y; Segal MR
Stat Appl Genet Mol Biol; 2005; 4():Article25. PubMed ID: 16646843
[TBL] [Abstract][Full Text] [Related]
22. Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.
Madurga S; Belda I; Llorà X; Giralt E
Protein Sci; 2005 Aug; 14(8):2069-79. PubMed ID: 16046628
[TBL] [Abstract][Full Text] [Related]
23. Modeling the structure of bound peptide ligands to major histocompatibility complex.
Tong JC; Tan TW; Ranganathan S
Protein Sci; 2004 Sep; 13(9):2523-32. PubMed ID: 15322290
[TBL] [Abstract][Full Text] [Related]
24. Predicting B cell epitope residues with network topology based amino acid indices.
Huang J; Honda W; Kanehisa M
Genome Inform; 2007; 19():40-9. PubMed ID: 18546503
[TBL] [Abstract][Full Text] [Related]
25. Immunological validation of the EpitOptimizer program for streamlined design of heteroclitic epitopes.
Houghton CS; Engelhorn ME; Liu C; Song D; Gregor P; Livingston PO; Orlandi F; Wolchok JD; McCracken J; Houghton AN; Guevara-Patiño JA
Vaccine; 2007 Jul; 25(29):5330-42. PubMed ID: 17570567
[TBL] [Abstract][Full Text] [Related]
26. Analysis of peptide-protein binding using amino acid descriptors: prediction and experimental verification for human histocompatibility complex HLA-A0201.
Guan P; Doytchinova IA; Walshe VA; Borrow P; Flower DR
J Med Chem; 2005 Nov; 48(23):7418-25. PubMed ID: 16279801
[TBL] [Abstract][Full Text] [Related]
27. New horizons in mouse immunoinformatics: reliable in silico prediction of mouse class I histocompatibility major complex peptide binding affinity.
Hattotuwagama CK; Guan P; Doytchinova IA; Flower DR
Org Biomol Chem; 2004 Nov; 2(22):3274-83. PubMed ID: 15534705
[TBL] [Abstract][Full Text] [Related]
28. Predicting the binding affinity of epitope-peptides with HLA-A*0201 by encoding atom-pair non-covalent interaction information between receptor and ligands.
Hu L; Ai Z; Liu P; Xiong Q; Min M; Lan C; Wang J; Fan L; Chen D
Chem Biol Drug Des; 2010 Jun; 75(6):597-606. PubMed ID: 20565476
[TBL] [Abstract][Full Text] [Related]
29. Quantitative structure-activity relationships and the prediction of MHC supermotifs.
Doytchinova IA; Guan P; Flower DR
Methods; 2004 Dec; 34(4):444-53. PubMed ID: 15542370
[TBL] [Abstract][Full Text] [Related]
30. In silico grouping of peptide/HLA class I complexes using structural interaction characteristics.
Tong JC; Tan TW; Ranganathan S
Bioinformatics; 2007 Jan; 23(2):177-83. PubMed ID: 17090577
[TBL] [Abstract][Full Text] [Related]
31. Improving MHC binding peptide prediction by incorporating binding data of auxiliary MHC molecules.
Zhu S; Udaka K; Sidney J; Sette A; Aoki-Kinoshita KF; Mamitsuka H
Bioinformatics; 2006 Jul; 22(13):1648-55. PubMed ID: 16613909
[TBL] [Abstract][Full Text] [Related]
32. Predicting peptides bound to I-Ag7 class II histocompatibility molecules using a novel expectation-maximization alignment algorithm.
Chang KY; Suri A; Unanue ER
Proteomics; 2007 Feb; 7(3):367-77. PubMed ID: 17211830
[TBL] [Abstract][Full Text] [Related]
33. Molecular dynamics and structure-based drug design for predicting non-natural nonapeptide binding to a class I MHC protein.
Scapozza L; Rognan D; Folkers G; Daser A
Acta Crystallogr D Biol Crystallogr; 1995 Jul; 51(Pt 4):541-9. PubMed ID: 15299842
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of different generic in silico methods for predicting HLA class I binding peptide vaccine candidates using a reverse approach.
Gowthaman U; Chodisetti SB; Parihar P; Agrewala JN
Amino Acids; 2010 Nov; 39(5):1333-42. PubMed ID: 20379752
[TBL] [Abstract][Full Text] [Related]
35. Toward the quantitative prediction of T-cell epitopes: QSAR studies on peptides having affinity with the class I MHC molecular HLA-A*0201.
Zhihua L; Yuzhang W; Bo Z; Bing N; Li W
J Comput Biol; 2004; 11(4):683-94. PubMed ID: 15579238
[TBL] [Abstract][Full Text] [Related]
36. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201--a new tool for epitope discovery.
Buchli R; VanGundy RS; Hickman-Miller HD; Giberson CF; Bardet W; Hildebrand WH
Biochemistry; 2005 Sep; 44(37):12491-507. PubMed ID: 16156661
[TBL] [Abstract][Full Text] [Related]
37. Integrating in silico and in vitro analysis of peptide binding affinity to HLA-Cw*0102: a bioinformatic approach to the prediction of new epitopes.
Walshe VA; Hattotuwagama CK; Doytchinova IA; Wong M; Macdonald IK; Mulder A; Claas FH; Pellegrino P; Turner J; Williams I; Turnbull EL; Borrow P; Flower DR
PLoS One; 2009 Nov; 4(11):e8095. PubMed ID: 19956609
[TBL] [Abstract][Full Text] [Related]
38. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
[TBL] [Abstract][Full Text] [Related]
39. Peptide-binding motif prediction by using phage display library for SasaUBA*0301, a resistance haplotype of MHC class I molecule from Atlantic Salmon (Salmo salar).
Zhao H; Hermsen T; Stet RJ; Skjødt K; Savelkoul HF
Mol Immunol; 2008 Mar; 45(6):1658-64. PubMed ID: 18206244
[TBL] [Abstract][Full Text] [Related]
40. Ab-initio conformational epitope structure prediction using genetic algorithm and SVM for vaccine design.
Moghram BA; Nabil E; Badr A
Comput Methods Programs Biomed; 2018 Jan; 153():161-170. PubMed ID: 29157448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
